Avacta enters research collaboration with OncoSec

By

Sharecast News | 22 Jan, 2018

17:23 04/10/24

  • 49.50
  • -1.39%-0.70
  • Max: 52.33
  • Min: 48.00
  • Volume: 1,767,111
  • MM 200 : 0.68

Avacta Group announced on Monday that it and OncoSec Medical Incorporated have entered into a research collaboration to combine Avacta's ‘Affimer’ protein platform with OncoSec's gene delivery technology ‘ImmunoPulse’.

Last news

Sunday newspaper round-up: Climate Change, The Telegraph, Stamp duty
Europe close: Stocks rise on bumper US jobs report
London close: FTSE ends flat after blowout payrolls report
MicroSalt makes progress in expanding patent portfolio
Woodbois raises £1m from new and existing shareholders